APRE icon

Aprea Therapeutics

66 hedge funds and large institutions have $50.3M invested in Aprea Therapeutics in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$1.99M
2 +$1.67M
3 +$1.12M
4
CCM
CAAS Capital Management
New York
+$906K
5
Two Sigma Investments
Two Sigma Investments
New York
+$781K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$167K
27
$149K
28
$147K
29
$133K
30
$129K
31
$118K
32
$114K
33
$104K
34
$80K
35
$76K
36
$74K
37
$58K
38
$53K
39
$53K
40
$50K
41
$48K
42
$42K
43
$41K
44
$35K
45
$27K
46
$27K
47
$18K
48
$16K
49
$15K
50
$14K